StockData
Cigna Group logo

Cigna Group

CINYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026Score 8/30
$295.19−3.04 (-1.02%)

Close on Nov 2, 2026Market cap $78.00BP/E –Yield 2.05%

Cigna Pharmaceutical Manufacturer Receivables by Quarter

Pharmaceutical Manufacturer Receivables — Drug Rebates & Discounts Receivable ($M) ($M)

QuarterlyAnnual

Cigna Pharmaceutical Manufacturer Receivables: $13,940M in Q2 2026, down 1.1% from a year earlier.

Latest, Q2 2026
13,940
Period ended Jun 30, 2026
Change on a year earlier
-1.1%
14,094 in Q2 2025
History
22 quarters
Since Q4 2018
Sources
21
Documents cited below

Where the Q2 2026 figure comes from

Source: SEC Form 10-Q (filed 2026-07-30) ↗

Rebates & administrative fees due from pharmaceutical manufacturers (hidden inside consolidated Accounts Receivable on the GAAP balance sheet).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPharmaceutical Manufacturer Receivables — Drug Rebates & Discounts Receivable ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202613,940-1.1%SEC Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 202610,914-4.2%SEC Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 202512,437–SEC Form 10-Q (filed 2026-07-30) ↗
Q3 2025Sep 30, 202514,405–SEC Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 202514,094–SEC Form 10-Q (filed 2025-07-31) ↗
Q1 2025Mar 31, 202511,393–SEC Form 10-Q (filed 2025-05-02) ↗
Q3 2023Sep 30, 20238,188+16.9%SEC Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 20237,922–SEC Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 20237,845–SEC Form 10-Q (filed 2023-05-05) ↗
Q4 2022Dec 31, 20227,108–SEC Form 10-K (filed 2024-02-29) ↗
Q3 2022Sep 30, 20227,005+7.3%SEC Form 10-Q (filed 2022-11-03) ↗
Q3 2021Sep 30, 20216,526+20.1%SEC Form 10-Q (filed 2021-11-04) ↗
Q2 2021Jun 30, 20216,123+31.6%SEC Form 10-Q (filed 2021-08-05) ↗
Q1 2021Mar 31, 20214,978+37.1%SEC Form 10-Q (filed 2021-05-07) ↗
Q4 2020Dec 31, 20204,676+36.0%SEC Form 10-K (filed 2022-02-24) ↗
Q3 2020Sep 30, 20205,433+37.4%SEC Form 10-Q (filed 2020-11-05) ↗

Cite this data

StockData. (2026). Cigna Pharmaceutical Manufacturer Receivables ($M), quarterly Q4 2018–Q2 2026 [Data set]. Compiled from Cigna SEC filings and investor materials. https://stockdatahq.com/stocks/ci/kpis/pharma-mfg-receivable

See every metric in the Cigna KPI table. Data updated Oct 31, 2026.